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Introduction. Huntington’s disease (HD) is a rare neurodegenerative disorder with no cure available. 
Among all the deregulated molecular mechanisms characterizing the disease, aberrant metabolism of 
gangliosides, sialic-acid containing glycosphingolipids, represents a critical determinant in its pathogenesis 
and a potential therapeutic target. Although still under investigation, such dysfunction seems to be, at least 
in part, attributable to a significant reduction in the expression of some of the sialyltransferases, classically 
involved in the synthesis of both gangliosides and glycoproteins. 
Hypothesis. Considering the role of sialyltransferases in the synthesis of glycoproteins, the main hypothesis 
of this study is that the aberrant ganglioside metabolism in HD may represent the result of an overall 
perturbed metabolism of sialo-conjugates. 
Aim. Here, we evaluated whether an overall impairment of brain sialo-conjugate metabolism really occurs 
in HD and may represent a potential novel therapeutic target. 
Results. Our data indicate that levels of Polysialic Acid (PSA), a sugar polymer exclusively linked to proteins 
and normally synthesized by two different sialyltransferases -ST8SIA2 and ST8SIA4-, is perturbed in brain 
tissues from a HD mouse model at different stage of the disease. The aberrant PSA content seems to 
depend on deregulated expression of ST8SIA2 and ST8SIA4. In line with our expectation, although still not 
conclusive, mRNA levels of these enzymes are clearly deregulated in brain tissues from HD mice. 
Conclusions. Our results support the idea that metabolism of sialo-conjugates may be globally impaired in 
HD, thus its modulation may likely represent a potential novel and alternative therapeutic strategy to treat 
the disease. 
 
